World News
-
FDA approves ASCENIV for the treatment of primary humoral immunodeficiency disease
World | News | 0 Comment | 02 Apr, 2019
ADMA Biologics, a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manufactures, markets and develops plasma-derived biologics for the treat...Read more
-
Jonas Bergh receives first ESMO Breast Cancer Award
World | News | 0 Comment | 02 Apr, 2019
The European Society for Medical Oncology (ESMO) announced that Prof. Jonas Bergh from the Karolinska Institutet in Stockholm will receive the newly established 2019 ESMO Breast Cancer Awar...Read more
-
Thermo Fisher showcases clinical analytical solutions at MSACL US 2019
World | News | 0 Comment | 02 Apr, 2019
Thermo Fisher Scientific announces the expansion of its portfolio of analytical instruments for clinical diagnostic laboratories with the addition of three systems now listed as Class I med...Read more
-
FDA advances policy changes to modernize mammography
World | News | 1 Comment | 02 Apr, 2019
The U.S. Food and Drug Administration (FDA) has announced important new steps to modernize breast cancer screening and help empower patients with more information when they are considering ...Read more
-
World | News | 0 Comment | 01 Apr, 2019
Celgene Corporation has announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted positive opinions for two triplet regimens bas...Read more
-
Boehringer Ingelheim acquires ICD Therapeutics
World | News | 0 Comment | 01 Apr, 2019
Boehringer Ingelheim has announced that it has acquired ICD Therapeutics. The acquisition includes rights to ICD’s innovative MacroDel biologics-delivery platform. Boehringer Ing...Read more
-
Cambridge Innovation Capital raises GBP150 million
World | News | 0 Comment | 01 Apr, 2019
Cambridge Innovation Capital plc (CIC), the venture capital investor focused on intellectual property rich technology and life science businesses in the Cambridge ecosystem, has completed a...Read more
-
Diseases cost the African Region $2.4 trillion a year: WHO
World | News | 0 Comment | 01 Apr, 2019
The World Health Organization (WHO) estimates that nearly 630 million years of healthy life were lost in 2015 due to the diseases afflicting the population across its 47 Member States in Af...Read more
-
Scientists identify FLIP Inhibitors for cancer treatment
World | News | 0 Comment | 29 Mar, 2019
Queen’s University Belfast and Domainex are pleased to announce that their joint project team has successfully identified novel first-in-class small molecule inhibitors of the an...Read more
-
EmeryStation West secures lease with Novartis
World | News | 0 Comment | 29 Mar, 2019
Wareham Development announced that it has executed a lease for 78,000 square feet over several floors of the newly-constructed 265,000 square foot EmeryStation West laboratory/office/transi...Read more
-
Gilead launches HepConnect initiative to combat Hepatitis C infections
World | News | 0 Comment | 29 Mar, 2019
Gilead Sciences, Inc. has announced HepConnect, a five-year, multi-million dollar initiative aimed at addressing the sharp increase in chronic hepatitis C (HCV) infections fueled by the nat...Read more
-
Novartis’ Mayzent gets FDA nod to treat multiple sclerosis
World | News | 0 Comment | 27 Mar, 2019
Novartis has received the US Food and Drug Administration (FDA) approval of Mayzent® (siponimod) for the treatment of adults with relapsing forms of multiple sclerosis, including s...Read more
-
Lilly, ImmuNext to develop new medicines for autoimmune diseases
World | News | 0 Comment | 27 Mar, 2019
Eli Lilly and Company and ImmuNext, Inc. have announced a global licensing and research collaboration focused on the study of a preclinical novel target that could lead to potential new med...Read more
-
Scientist Kiana Aran makes digital detection of DNA without amplification possible
World | News | 0 Comment | 26 Mar, 2019
Researchers have found multiple applications for the CRISPR (Clustered Regularly Interspersed Short Palindromic Repeats) gene editing technology since it came into use by the scientific com...Read more
-
Pilloxa initiates a strategic partnership with Bayer AB
World | News | 0 Comment | 26 Mar, 2019
Swedish digital health start-up Pilloxa has entered a strategic collaboration with Bayer AB. Pilloxa helps patients take their medicine in time by using an app that is connected to a smar...Read more
-
Impulse Dynamics receives FDA approval for breakthrough Optimizer®
World | News | 0 Comment | 25 Mar, 2019
Impulse Dynamics, developer of the implantable Optimizer® Smart System for delivering CCM™ therapy, announced that it has received approval from the United States Food a...Read more
-
Muno-Vax Biotechnologies launches Dentavax to combat gingivitis
World | News | 0 Comment | 25 Mar, 2019
Dentavax, developed by Muno-Vax Biotechnologies, gives your oral mucosa's immune system a boost to minimize gingivitis, and help keep your gums and teeth healthy. All Muno-Vax supplements h...Read more
-
Ascendis Pharma announces top-line results for Ph3 heiGHt Trial
World | News | 0 Comment | 25 Mar, 2019
Ascendis Pharma A/S, a biopharmaceutical company that utilizes its innovative TransCon technology to address unmet medical needs, has announced top-line results from its pivotal phase 3 hei...Read more
